MedAvail Inc. (MDVL)
NASDAQ: MDVL
· Real-Time Price · USD
1.80
-1.37 (-43.22%)
At close: Feb 12, 2024, 10:00 PM
MedAvail Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 23.84M | 34.62M | 43.11M | 39.04M | 33.37M | 27.22M | 22.13M | 17.95M | 19.3M | 16.58M |
Cost of Revenue | 22.23M | 32.27M | 40.52M | 36.69M | 32.13M | 26.72M | 21.81M | 17.52M | 14.07M | 11.08M |
Gross Profit | 1.6M | 2.34M | 2.58M | 2.35M | 1.24M | 498K | 317K | 434K | 5.23M | 5.5M |
Operating Income | -31.7M | -38.66M | -46.42M | -48.05M | -47.58M | -46.63M | -43.51M | -42.81M | -33.82M | -29.63M |
Interest Income | 463K | 317K | 317K | 321K | 13K | 40K | 79K | 103K | 96K | 76K |
Pretax Income | -40.93M | -47.13M | -47.59M | -49.15M | -48.61M | -47.38M | -43.81M | -43.27M | -34.49M | -30.56M |
Net Income | -46.48M | -52.41M | -48.18M | -49.74M | -48.89M | -47.64M | -43.81M | -43.27M | -34.49M | -30.56M |
Selling & General & Admin | 27.15M | 31.13M | 38.31M | 39.48M | 38.56M | 40.01M | 35.63M | 35.1M | 30.13M | 25.3M |
Research & Development | 662K | 798K | 1.11M | 1.2M | 1.25M | 1.17M | 849K | 750K | 672K | 634K |
Other Expenses | 5.43M | 9.08M | 9.58M | 5.49M | 4M | 385K | 45K | 96K | 482K | 686K |
Operating Expenses | 33.3M | 41.01M | 49.01M | 50.4M | 48.83M | 47.13M | 43.83M | 41.17M | 35.65M | 30.44M |
Interest Expense | 957K | 1.09M | 1.17M | 1.11M | 1.05M | 841K | 589K | 656K | 851K | 1.06M |
Selling & Marketing Expenses | 2.06M | 4.35M | 6.53M | 6.93M | 8.55M | 7.74M | 6.8M | 5.8M | 4.64M | 3.72M |
Cost & Expenses | 55.54M | 73.28M | 89.53M | 87.09M | 80.95M | 73.84M | 65.64M | 58.68M | 49.72M | 41.52M |
Income Tax Expense | 5.55M | 5.28M | 591K | 588K | 275K | 355K | 102K | -235K | 218K | 391K |
Shares Outstanding (Basic) | 1.8M | 1.61M | 1.61M | 1.57M | 1.39M | 658.44K | 657.04K | 655.02K | 650.93K | 648.8K |
Shares Outstanding (Diluted) | 1.8M | 1.61M | 1.61M | 1.6M | 1.39M | 658.44K | 657.04K | 655.02K | 650.93K | 648.8K |
EPS (Basic) | -28.72 | -33.96 | -43.22 | -55.54 | -65.05 | -72.67 | -67.08 | -203.44 | -247.04 | -398.29 |
EPS (Diluted) | -28.59 | -33.82 | -43.08 | -55.4 | -65.04 | -72.67 | -67.08 | -203.44 | -247.04 | -398.29 |
EBITDA | -38.51M | -43.76M | -43.37M | -44.23M | -44.79M | -43.88M | -40.85M | -37.22M | -27.22M | -21.94M |
EBIT | -39.97M | -49.69M | -54M | -55.62M | -55.14M | -50.47M | -43.22M | -42.63M | -33.65M | -29.51M |
Depreciation & Amortization | 2.21M | 2.44M | 3.03M | 3.81M | 2.76M | 2.67M | 2.58M | 2.36M | 2.06M | 1.92M |